Loading…

Rapid monitoring of recombinant protein products: a comparison of current technologies

Specific measurement of recombinant protein titer in a complex environment during industrial bioprocessing has traditionally relied on labor-intensive and time-consuming immunoassays. In recent years, however, developments in analytical technology have resulted in improved methods for protein produc...

Full description

Saved in:
Bibliographic Details
Published in:Trends in biotechnology (Regular ed.) 2002-04, Vol.20 (4), p.149-156
Main Authors: Baker, Kym N, Rendall, Mark H, Patel, Ashvin, Boyd, Paul, Hoare, Mike, Freedman, Robert B, James, David C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Specific measurement of recombinant protein titer in a complex environment during industrial bioprocessing has traditionally relied on labor-intensive and time-consuming immunoassays. In recent years, however, developments in analytical technology have resulted in improved methods for protein product monitoring during bioprocessing. The choice of product-monitoring technology for a particular bioprocess will depend on a variety of assay factors and instrument-specific factors. In this article, we have compiled an overview of the advantages and disadvantages of the most commonly used technologies used: electrochemiluminescence, optical biosensors, rapid chromatography and nephelometry. The advantages of each technology for measuring both small and large recombinant therapeutic proteins are compared with a conventional enzyme-linked immunosorbent assay (ELISA) technique. Recently, developments in analytical technology have resulted in improved methods for protein product monitoring during bioprocessing. The advantages and disadvantages of different technologies are discussed here.
ISSN:0167-7799
1879-3096
DOI:10.1016/S0167-7799(01)01914-X